Clin Mol Hepatol.
2023 Apr;29(2):342-344. 10.3350/cmh.2023.0106.
Management of hepatocellular carcinoma in China: Seeking common grounds while reserving differences
- Affiliations
-
- 1Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Naval Medical University), Shanghai, China
- KMID: 2541412
- DOI: http://doi.org/10.3350/cmh.2023.0106
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The clinical management of hepatocellular carcinoma in China: Progress and challenges
- The prime time for management of hepatocellular carcinoma in Hong Kong
- Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison
- 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
- Metabolic dysfunction-associated fatty liver disease related hepatocellular carcinoma in China: An increasing problem: Letter to the edior on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”
